Approval · Notice of Compliance 24906 · 2020
TECTA: Notice of Compliance 24906
Issued December 30, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 24906
- Date
- December 30, 2020
- Company
- Takeda Canada IncorporatedToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- To add safety information regarding drug rash with eosinophilia and systemic symptoms (DRESS), hypercalcemia and a minor update to the Warnings and Precautions section in relation to hypocalcemia
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TECTA | Not yet assigned | — |
Medicinal ingredients
- PANTOPRAZOLE MAGNESIUM 40 MG per TAB